Cargando…
502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472565/ http://dx.doi.org/10.1016/j.annonc.2022.07.630 |
| _version_ | 1784789328938926080 |
|---|---|
| author | Bakouny, Z. Grover, P. Labaki, C. Awosika, J. Gulati, S. Hsu, C-Y. Bilen, M.A. Eton, O. Fecher, L. Hwang, C. Khan, H. McKay, R.R. Ruiz, E. Weissmann, L. Thompson, M.A. Shah, D. Warner, J. Shyr, Y. Choueiri, T.K. Wise-Draper, T. |
| author_facet | Bakouny, Z. Grover, P. Labaki, C. Awosika, J. Gulati, S. Hsu, C-Y. Bilen, M.A. Eton, O. Fecher, L. Hwang, C. Khan, H. McKay, R.R. Ruiz, E. Weissmann, L. Thompson, M.A. Shah, D. Warner, J. Shyr, Y. Choueiri, T.K. Wise-Draper, T. |
| author_sort | Bakouny, Z. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9472565 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94725652022-09-14 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer Bakouny, Z. Grover, P. Labaki, C. Awosika, J. Gulati, S. Hsu, C-Y. Bilen, M.A. Eton, O. Fecher, L. Hwang, C. Khan, H. McKay, R.R. Ruiz, E. Weissmann, L. Thompson, M.A. Shah, D. Warner, J. Shyr, Y. Choueiri, T.K. Wise-Draper, T. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-09 2022-09-13 /pmc/articles/PMC9472565/ http://dx.doi.org/10.1016/j.annonc.2022.07.630 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Bakouny, Z. Grover, P. Labaki, C. Awosika, J. Gulati, S. Hsu, C-Y. Bilen, M.A. Eton, O. Fecher, L. Hwang, C. Khan, H. McKay, R.R. Ruiz, E. Weissmann, L. Thompson, M.A. Shah, D. Warner, J. Shyr, Y. Choueiri, T.K. Wise-Draper, T. 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer |
| title | 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer |
| title_full | 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer |
| title_fullStr | 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer |
| title_full_unstemmed | 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer |
| title_short | 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer |
| title_sort | 502p association of immunotherapy and immunosuppression with severe covid-19 disease in patients with cancer |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472565/ http://dx.doi.org/10.1016/j.annonc.2022.07.630 |
| work_keys_str_mv | AT bakounyz 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT groverp 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT labakic 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT awosikaj 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT gulatis 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT hsucy 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT bilenma 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT etono 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT fecherl 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT hwangc 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT khanh 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT mckayrr 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT ruize 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT weissmannl 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT thompsonma 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT shahd 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT warnerj 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT shyry 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT choueiritk 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer AT wisedrapert 502passociationofimmunotherapyandimmunosuppressionwithseverecovid19diseaseinpatientswithcancer |